New DNA therapy tested in 8 patients with advanced cancer
NCT ID NCT06736275
First seen Jan 09, 2026 · Last updated May 14, 2026 · Updated 27 times
Summary
This early-phase study tested a new DNA-based treatment called SXRN in 8 people with advanced solid tumors who had no other standard options. The main goal was to check safety and find the best dose, not to cure the cancer. The treatment aims to control the disease, but patients may still need ongoing care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CACHEXIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cancer Hospital Chinese Academy of Medical Sciences
Beijing, 100021, China
Conditions
Explore the condition pages connected to this study.